WOOJUNG BIO Inc (215380) — Capital Reinvestment Ratio
WOOJUNG BIO Inc (215380) has a Capital Reinvestment Ratio of 0.12x as of March 2025, meaning it reinvests 0% of its operating cash flow (₩1.59 Billion) in capital expenditures (₩191.51 Million). See 215380 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
WOOJUNG BIO Inc Capital Reinvestment Ratio (2019–2022)
This chart tracks WOOJUNG BIO Inc's Capital Reinvestment Ratio across 3 annual periods. Check how aggressively does WOOJUNG BIO Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for WOOJUNG BIO Inc (2019–2022)
Year-by-year Capital Reinvestment Ratio for WOOJUNG BIO Inc from 2019 to 2022. For live market cap and broader valuation context, see how much is WOOJUNG BIO Inc worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 4.56x | ₩2.50 Billion | ₩11.42 Billion | ▼ -78.5% |
| 2021 | 21.23x | ₩1.73 Billion | ₩36.68 Billion | ▲ +105.0% |
| 2019 | 10.36x | ₩208.72 Million | ₩2.16 Billion | — |